Goldman SachsGSBUYSep 14, 2026Stock price when the opinion was issued
As of Sep 15, 2026. Market Open.
Different businesses. LLY is a big play in GLP-1 drugs. How will pills effect the injections business? LLY has done a good job of navigating these new pills. GS enjoys increased stock market and IPO businesses. He prefers LLY, which is tied to a secular growth trend, but GS' good times in capturing revenue in this cycle will end.
Mergers are increasing, and banks like GS makes advisory fees from them. Also, the banks have been rallying since oil slumped, and will benefit further from rising interest rates, which appears will happen later this year. Plus, hyperscalers may need to keep borrowing money to keep competing with each other.
The banks look great here. A higher interest rate will make the banks a little more money, not a lot. The banks are a hedge on the economy. They have enough M&A activity and IPOs, too.